Transgene site-specific integration: Problems and solutions

Topics in Current Genetics

Volumn 23, Issue , 2013, Pages 3-39

  Bire, Solenne ^a   Rouleux Bonnin, Florence ^a  

^a UNIVERSITÉ DE TOURS   (France)

Author keywords

Genotoxicity; Insertional mutagenesis; Safe harbor locus; Site specificity; Transgene silencing; Transgene targeting

Indexed keywords

EID: 84865404755     PISSN: 16102096     EISSN: 16106970     Source Type: Book Series    
DOI: 10.1007/978-94-007-4531-5_1     Document Type: Article

References (225)

1. Ahangarani RR, Janssens W, Carlier V et al (2011) Retroviral vectors induce epigenetic chromatin modi fications and IL-10 production in transduced B cells via activation of toll-like receptor 2. Mol Ther 19:711-722
2. Arnould S, Chames P, Perez C et al (2006) Engineering of large numbers of highly specific homing endonucleases that induce recombination on novel DNA targets. J Mol Biol 355:443-458
3. Aubert M, Ryu BY, Banks L et al (2011) Successful targeting and disruption of an integrated reporter lentivirus using the engineered homing endonuclease Y2 I-AniI. PLoS One 6:e16825
4. Balciunas D, Wangensteen KJ, Wilber A et al (2006) Harnessing a high cargo-capacity transposon for genetic applications in vertebrates. PLoS Genet 2:e169
5. Barber GN (2011) Innate immune DNA sensing pathways: STING, AIMII and the regulation of interferon production and inflammatory responses. Curr Opin Immunol 23:10-20
6. Barski A, Cuddapah S, Cui K et al (2007) High-resolution pro filing of histone methylations in the human genome. Cell 29:823-837
7. Bartholomew C, Ihle JN (1991) Retroviral insertions 90 kilobases proximal to the Evi-1 myeloid transforming transforming gene activate transcription from the normal promoter. Mol Cell Biol 11:1820-1828
8. Baum C, Düllmann J, Li Z et al (2003) Side effects of retroviral gene transfer into hematopoietic stem cells. Blood 101:2099-2114
9. Baum C, Kustikova O, Modlich U et al (2006) Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors. Hum Gene Ther 17:252-263
10. Beerli RR, Barbas CF 3rd (2002) Engineering polydactyl zinc-finger transcription factors. Nat Biotechnol 20:135-141
11. Ben Ali A, Wuyts J, De Wachter R et al (1999) Construction of a variability map for eukaryotic large subunit ribosomal RNA. Nucleic Acids Res 27:2825-2831
12. Biasco L, Ambrosi A, Pellin D et al (2010) Integration pro file of retroviral vector in gene therapy treated patients is cell-specific according to gene expression and chromatin conformation of target cell. EMBO Mol Med 3:89-101
13. Birling MC, Gof flot F, Warot X (2009) Site-specific recombinases for manipulation of the mouse genome. Methods Mol Biol 561:245-263
14. Bower DM, Prather KL (2009) Engineering of bacterial strains and vectors for the production of plasmid DNA. Appl Microbiol Biotechnol 82:805-813
15. Bowie AG, Fitzgerald KA (2007) RIG-I: tri-ing to discriminate between self and non-self RNA. Trends Immunol 28:147-150
16. Breckpot K, Escors D, Arce F et al (2010) HIV-1 lentiviral vector immunogenicity is mediated by Toll-like receptor 3 (TLR3) and TLR7. J Virol 84:5627-5636
17. Bronson SK, Plaehn EG, Kluckman KD et al (1996) Single-copy transgenic mice with chosen-site integration. Proc Natl Acad Sci USA 93:9067-9072
18. Cadinanos J, Bradley A (2007) Generation of an inducible and optimized piggyBac transposon system. Nucleic Acids Res 35:e87
19. Carnes AE, Luke JM, Vincent JM et al (2011) Plasmid DNA fermentation strain and process-specific effects on vector yield, quality, and transgene expression. Biotechnol Bioeng 108:354-363
20. Casola S (2010) Mouse models for miRNA expression: the ROSA26 locus. Methods Mol Biol 667:145-163
21. Cattoglio C, Facchini G, Sartori D et al (2007) Hot spots of retroviral integration in human CD34+ hematopoietic cells. Blood 110:1770-1778
22. Cattoglio C, Maruggi G, Bartholomae C et al (2010a) High-de finition mapping of retroviral integration sites de fines the fate of allogeneic T cells after donor lymphocyte infusion. PLoS One 5:e15688
23. Cattoglio C, Pellin D, Rizzi E et al (2010b) High-de finition mapping of retroviral integration sites identi fies active regulatory elements in human multipotent hematopoietic progenitors. Blood 116:5507-5517
24. Chen CM, Krohn J, Bhattacharya S et al (2011) A comparison of exogenous promoter activity at the ROSA26 locus using a PhiC31 integrase mediated cassette exchange approach in mouse ES cells. PLoS One 6:e23376
25. Ciceri F, Bonini C, Marktel S et al (2007) Antitumor effects of HSV-TK-engineered donor lymphocytes after allogeneic stem-cell transplantation. Blood 109:4698-4707
26. Ciceri F, Bonini C, Stanghellini MT et al (2009) Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study. Lancet Oncol 10:489-500
27. Ciuf fiA, Llano M, Poeschla E et al (2005) A role for LEDGF/p75 in targeting HIV DNA integration. Nat Med 11:1287-1289
28. Cohen-Tannoudji M, Robine S, Choulika A et al (1998) I-SceI-induced gene replacement at a natural locus in embryonic stem cells. Mol Cell Biol 18:1444-1448
29. Cui K, Zang C, Roh TY et al (2009) Chromatin signatures in multipotent human hematopoietic stem cells indicate the fate of bivalent genes during differentiation. Cell Stem Cell 4:80-93
30. Dalsgaard T, Moldt B, Sharma N et al (2009) Shielding of sleeping beauty DNA transposon-delivered transgene cassettes by heterologous insulators in early embryonal cells. Mol Ther 17:121-130
31. Dang CV, Lee WMF (1989) Nuclear and nucleolar targeting sequences of c-erb-A, c-myb, N-myc, p53, HSP70, and HIV tat proteins. J Biol Chem 264:18019-18023
32. de Felipe P (2002) Polycistronic viral vectors. Curr Gene Ther 2:355-378
33. DeKelver RC, Choi VM, Moehle EA et al (2010) Functional genomics, proteomics, and regulatory DNA analysis in isogenic settings using zinc finger nuclease-driven transgenesis into a safe harbor locus in the human genome. Genome Res 20:1133-1142
34. Deyle DR, Russell DW (2009) Adeno-associated virus vector integration. Curr Opin Mol Ther 11:442-447
35. Dutheil N, Yoon-Robarts M, Ward P et al (2004) Characterization of the mouse adeno-associated virus AAVS1 ortholog. J Virol 78:8917-8921
36. Ehrhardt A, Engler JA, Xu H et al (2006) Molecular analysis of chromosomal rearrangements in mammalian cells after phiC31-mediated integration. Hum Gene Ther 17:1077-1094
37. Elbashir SM, Harborth J, Lendeckel W et al (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494-498
38. Ellis J (2005) Silencing and variegation of gammaretrovirus and lentivirus vectors. Hum Gene Ther 16:1241-1246
39. Emery DW (2011) The use of chromatin insulators to improve the expression and safety of integrating gene transfer vectors. Hum Gene Ther 22:761-774
40. Evans-Galea MV, Wielgosz MM, Hanawa H et al (2007) Suppression of clonal dominance in cultured human lymphoid cells by addition of the cHS4 insulator to a lentiviral vector. Mol Ther 15:801-809
41. Fehse B, Roeder I (2008) Insertional mutagenesis and clonal dominance: biological and statistical considerations. Gene Ther 15:143-153
42. Felice B, Cattoglio C, Cittaro D et al (2009) Transcription factor binding sites are genetic determinants of retroviral integration in the human genome. PLoS One 4:e4571
43. Fire A, Xu S, Montgomery MK et al (1998) Potent and specific genetic interference by doublestranded RNA in Caenorhabditis elegans . Nature 391:806-811
44. Fiszer-Kierzkowska A, Vydra N, Wysocka-Wycisk A et al (2011) Liposome-based DNA carriers may induce cellular stress response and change gene expression pattern in transfected cells. BMC Mol Biol 10:12-27
45. Galvan DL, Nakazawa Y, Kaja A et al (2009) Genome-wide mapping of PiggyBac transposon integrations in primary human T cells. J Immunother 32:837-844
46. Garrison BS, Yant SR, Mikkelsen JG, Kay MA (2007) Postintegrative gene silencing within the Sleeping Beauty transposition system. Mol Cell Biol 27:8824-8833
47. Gaszner M, Felsenfeld G (2006) Insulators: exploiting transcriptional and epigenetic mechanisms. Nat Rev Genet 7:703-713
48. Gautam A, Densmore CL, Waldrep JC (2001) Pulmonary cytokine responses associated with PEI-DNA aerosol gene therapy. Gene Ther 8:254-257
49. Georgopoulos LJ, Elgue G, Sanchez J et al (2009) Preclinical evaluation of innate immunity to baculovirus gene therapy vectors in whole human blood. Mol Immunol 46:2911-2917
50. Gersbach CA, Gaj T, Rm G et al (2011) Targeted plasmid integration into the human genome by an engineered zinc-finger recombinase. Nucleic Acids Res 39:7868-7878
51. Geurts AM, Collier LS, Geurts JL et al (2006) Gene mutations and genomic rearrangements in the mouse as a result of transposon mobilization from chromosomal concatemers. PLoS Genet 2:e156
52. Glimm H, Schmidt M, Fischer M et al (2005) Ef ficient marking of human cells with rapid but transient repopulating activity in autografted recipients. Blood 106:893-898
53. Golding MC, Mann MR (2011) A bidirectional promoter architecture enhances lentiviral transgenesis in embryonic and extraembryonic stem cells. Gene Ther 18:817-826
54. Gouble A, Smith J, Bruneau S et al (2006) Efficient in toto targeted recombination in mouse liver by meganuclease-induced double-strand break. J Gene Med 8:616-622
55. Goulaouic H, Chow SA (1996) Directed integration of viral DNA mediated by fusion proteins consisting of human immunode ficiency virus type 1 integrase and Escherichia coli LexA protein. J Virol 70:37-46
56. Grabundzija I, Irgang M, Mátés L et al (2010) Comparative analysis of transposable element vector systems in human cells. Mol Ther 18:1200-1209
57. Grewal SI, Moazed D (2003) Heterochromatin and epigenetic control of gene expression. Science 301:798-802
58. Grizot S, Smith J, Daboussi F et al (2009) Efficient targeting of a SCID gene by an engineered single-chain homing endonuclease. Nucleic Acids Res 37:5405-5419
59. Guo J, Gaj T, Barbas CF (2010) Directed evolution of an enhanced and highly Efficient FokI cleavage domain for zinc finger nucleases. J Mol Biol 400:96-107
60. Hacein-Bey-Abina S, von Kalle C, Schmidt M et al (2003a) A serious adverse event after successful gene therapy for X-linked severe combined immunode ficiency. N Engl J Med 348:255-256
61. Hacein-Bey-Abina S, von Kalle C, Schmidt M et al (2003b) LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302:415-419
62. Hamady M, Walker JJ, Harris JK et al (2008) Error-correcting barcoded primers for pyrosequencing hundreds of samples in multiplex. Nat Methods 5:235-237
63. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57-70
64. Händel EM, Cathomen T (2011) Zinc-finger nuclease based genome surgery: it's all about specificity. Curr Gene Ther 11:28-37
65. Hayashi T, Lamba DA, Slowik A et al (2010) A method for stabilizing RNA for transfection that allows control of expression duration. Dev Dyn 239:2034-2040
66. Heath PJ, Stephens KM, Monnat RJ Jr, Stoddard BL (1997) The structure of I-Crel, a group I intron-encoded homing endonuclease. Nat Struct Biol 4:468-476
67. Hematti P, Hong BK, Ferguson C et al (2004) Distinct genomic integration of MLV and SIV vectors in primate hematopoietic stem and progenitor cells. PLoS Biol 2:e423
68. Henckaerts E, Linden RM (2010) Adeno-associated virus: a key to the human genome? Future Virol 5:555-574
69. Hodges BL, Taylor KM, Joseph MF et al (2004) Long-term transgene expression from plasmid DNA gene therapy vectors is negatively affected by CpG dinucleotides. Mol Ther 10:269-278
70. Huang X, Yang Y (2009) Innate immune recognition of viruses and viral vectors. Hum Gene Ther 20:293-301
71. Huang X, Guo H, Tammana S et al (2010) Gene transfer Efficiency and genome-wide integration pro filing of Sleeping Beauty, Tol2, and piggyBac transposons in human primary T cells. Mol Ther 18:1803-1813
72. Irion S, Luche H, Gadue P et al (2007) Identi fication and targeting of the ROSA26 locus in human embryonic stem cells. Nat Biotechnol 25:1477-1482
73. Ishii KJ, Akira S (2005) TLR ignores methylated RNA? Immunity 23:111-113
74. Ishii KJ, Akira S (2008) Potential link between the immune system and metabolism of nucleic acids. Curr Opin Immunol 20:524-529
75. Ismail SI, Kingsman SM, Kingsman AJ, Uden M (2000) Split-intron retroviral vectors: enhanced expression with improved safety. J Virol 74:2365-2371
76. Ivics Z, Hackett PB, Plasterk RH, Izsvák Z (1997) Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell 91:501-510
77. Ivics Z, Katzer A, Stüwe EE, Fiedler D, Knespel S, Izsvák Z (2007) Targeted sleeping beauty transposition in human cells. Mol Ther 15:1137-1144
78. Jacobsen L, Calvin S, Lobenhofer E (2009) Transcriptional effects of transfection: the potential for misinterpretation of gene expression data generated from transiently transfected cells. Biotechniques 47:617-624
79. Jaenisch R, Bird A (2003) Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33(Suppl):245-254
80. Jähner D, Jaenisch R (1985) Chromosomal position and specific demethylation in enhancer sequences of germ line-transmitted retroviral genomes during mouse development. Mol Cell Biol 5:2212-2220
81. Jähner D, Stuhlmann H, Stewart CL et al (1982) De novo methylation and expression of retroviral genomes during mouse embryogenesis. Nature 298:623-628
82. Jasin M, Moynahan ME, Richardson C (1996) Targeted transgenesis. Proc Natl Acad Sci USA 93:8804-8808
83. Kameyam Y, Kawabe Y, Ito A, Kamihira M (2010) An accumulative site-specific gene integration system using cre recombinase-mediated cassette exchange. Biotechnol Bioeng 105: 1106-1114
84. Kaminski JM, Huber MR, Summers JB, Ward MB (2002) Design of a nonviral vector for siteselective, Efficient integration into the human genome. FASEB J 6:1242-1247
85. Karikó K, Bhuyan P, Capodici J et al (2004) Exogenous siRNA mediates sequence-independent gene suppression by signaling through toll-like receptor 3. Cells Tissues Organs 177:132-138
86. Karikó K, Buckstein M, Ni H, Weissman D (2005) Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modi fication and the evolutionary origin of RNA. Immunity 23:165-175
87. Kawashima T, Osanai M, Futahashi R (2007) A novel target-specific gene delivery system combining baculovirus and sequence-specific long interspersed nuclear elements. Virus Res 127:49-60
88. Kay MA, Glorioso JC, Naldini L (2001) Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med 7:33-40
89. Kedes LH (1979) Histone genes and histone messengers. Annu Rev Biochem 48:837-870
90. Kim YK, Kim VN (2007) Processing of intronic microRNAs. EMBO J 26:775-783
91. Kojima KK, Fujiwara H (2003) Evolution of target specificity in R1 clade non-LTR retrotransposon. Mol Biol Evol 20:351-361
92. Kojima KK, Fujiwara H (2004) Cross-genome screening of novel sequence-specific non-LTR retrotransposons: various multicopy RNA genes and microsatellites are selected as targets. Mol Biol Evol 21:207-217
93. Kolb AF, Coates CJ, Kaminski JM et al (2005) Site-directed genome modi fication: nucleic acid and protein modules for targeted integration and gene correction. Trends Biotechnol 23:399-406
94. Kormann MS, Hasenpusch G, Aneja MK et al (2011) Expression of therapeutic proteins after delivery of chemically modi fied mRNA in mice. Nat Biotechnol 29:154-157
95. Kouzarides T (2007) Chromatin modi fications and their function. Cell 128:693-705
96. Kustikova OS, Wahlers A, Kuhlcke K et al (2003) Dose finding with retroviral vectors: Correlation of retroviral vector copy numbers in single cells with gene transfer Efficiency in a cell population. Blood 102:3934-3937
97. Kustikova OS, Fehse B, Modlich U et al (2005) Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking. Science 308:1171-1174
98. Kustikova OS, Baum C, Fehse B (2008) Retroviral integration site analysis in hematopoietic stem cells. Methods Mol Biol 430:255-267
99. Kustikova O, Brugman M, Baum C (2010) The genomic risk of somatic gene therapy. Semin Cancer Biol 20:269-278
100. Lam AP, Dean DA (2010) Progress and prospects: nuclear import of nonviral vectors. Gene Ther 17:439-447
101. Lamartina S, Sporeno E, Fattori E, Toniatti C (2000) Characteristics of the adeno-associated virus preintegration site in human chromosome 19: open chromatin conformation and transcriptioncompetent environment. J Virol 74:7671-7677
102. Lechertier T, Sirri V, Hernandez-Verdun D, Roussel P (2007) A B23-interacting sequence as a tool to visualize protein interactions in a cellular context. J Cell Sci 120:265-375
103. Lesbats P, Botbol Y, Chevereau G et al (2011) Functional coupling between HIV-1 integrase and the SWI/SNF chromatin remodeling complex for Efficient in vitro integration into stable nucleosomes. PLoS Pathog 7:e1001280
104. Lewinski MK, Yamashita M, Emerman M et al (2006) Retroviral DNA integration: viral and cellular determinants of target-site selection. PLoS Pathog 2:e60
105. Li CL, Xiong D, Stamatoyannopoulos G, Emery DW (2009) Genomic and functional assays demonstrate reduced gammaretroviral vector genotoxicity associated with use of the cHS4 chromatin insulator. Mol Ther 17:716-724
106. Liu G, Geurts AM, Yae K et al (2005) Target-site preferences of Sleeping Beauty transposons. J Mol Biol 346:161-173
107. Liu X, Liu M, Xue Z et al (2007) Non-viral ex vivo transduction of human hepatocyte cells to express factor VIII using a human ribosomal DNA-targeting vector. J Thromb Haemost 5: 347-351
108. Liu Y, Lakshmipathy U, Ozgenc A et al (2010) hESC engineering by integrase-mediated chromosomal targeting. Methods Mol Biol 584:229-268
109. Lombardo A, Cesana D, Genovese P et al (2011) Site-specific integration and tailoring of cassette design for sustainable gene transfer. Nat Methods 8:861-869
110. Lu Z, Ghazizadeh S (2007) Loss of transgene following ex vivo gene transfer is associated with a dominant Th2 response: implications for cutaneous gene therapy. Mol Ther 15:954-961
111. Maison C, Almouzni G (2004) HP1 and the dynamics of heterochromatin maintenance. Nat Rev Mol Cell Biol 5:296-304
112. Manno CS, Pierce GF, Arruda VR et al (2006) Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat Med 12:342-347
113. Maragathavally KJ, Kaminski JM, Coates CJ (2006) Chimeric Mos1 and piggyBac transposases result in site-directed integration. FASEB J 20:1880-1882
114. Markusic DM, de Waart DR, Seppen J (2010) Separating lentiviral vector injection and induction of gene expression in time, does not prevent an immune response to rtTA in rats. PLoS One 5:e9974
115. Marshall HM, Ronen K, Berry C et al (2007) Role of PSIP1/LEDGF/p75 in lentiviral infectivity and integration targeting. PLoS One 2:e1340
116. Mates L, Izsvak Z, Ivics Z (2007) Technology transfer from worms and flies to vertebrates: transposition-based genome manipulations and their future perspectives. Genome Biol 8(Suppl 1):S1
117. Mates L, Chuah MK, Belay E et al (2009) Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates. Nat Genet 41:753-761
118. McConnell Smith A, Takeuchi R, Pellenz S et al (2009) Generation of a nicking enzyme that stimulates site-specific gene conversion from the I-AniI LAGLIDADG homing endonuclease. Proc Natl Acad Sci USA 106:5099-5104
119. McKenna SA, Kim I, Puglisi EV et al (2007) Puri fication and characterization of transcribed RNAs using gel filtration chromatography. Nat Protoc 2:3270-3277
120. Meir YJ, Weirauch MT, Yang HS et al (2011) Genome-wide target pro filing of piggyBac and Tol2 in HEK 293: pros and cons for gene discovery and gene therapy. BMC Biotechnol 11:28
121. Meister G, Tuschl T (2004) Mechanisms of gene silencing by double stranded RNA. Nature 431:343-349
122. Métais JY, Dunbar CE (2008) The MDS1-EVI1 gene complex as a retrovirus integration site: impact on behavior of hematopoietic cells and implications for gene therapy. Mol Ther 6:439-449
123. Mikkelsen JG, Yant SR, Meuse L et al (2003) Helper-independent Sleeping Beauty transposontransposase vectors for Efficient nonviral gene delivery and persistent gene expression in vivo . Mol Ther 8:654-665
124. Miller A, Dean D (2009) Tissue-specific and transcription factor-mediated nuclear entry of DNA. Adv Drug Deliv Rev 61:603-613
125. Mingozzi F, High KA (2011) Immune Responses to AAV in Clinical Trials. Curr Gene Ther 11:321-330
126. Miranda TB, Jones PA (2007) DNA methylation: the nuts and bolts of repression. J Cell Physiol 213:384-390
127. Miskey C, Izsvak Z, Kawakami K, Ivics Z (2005) DNA transposons in vertebrate functional genomics. Cell Mol Life Sci 62:629-641
128. Modlich U, Bohne J, Schmidt M et al (2006) Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity. Blood 108:2545-2553
129. Modlich U, Navarro S, Zychlinski D et al (2009) Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors. Mol Ther 17:1919-1928
130. Moldt B, Yant SR, Andersen PR et al (2007) Cis-acting gene regulatory activities in the terminal regions of sleeping beauty DNA transposon-based vectors. Hum Gene Ther 18:1193-1204
131. Montini E, Cesana D, Schmidt M et al (2006) Hematopoietic stem cell gene transfer in a tumorprone mouse model uncovers low genotoxicity of lentiviral vector integration. Nat Biotechnol 24:687-696
132. Montini E, Cesana D, Schmidt M et al (2009) The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy. J Clin Invest 119:964-975
133. Morales ME, Mann VH, Kines KJ et al (2007) PiggyBac transposon mediated transgenesis of the human blood fluke, Schistosoma mansoni. FASEB J 21:3479-3489
134. Moreno-Carranza B, Gentsch M, Stein S et al (2009) Transgene optimization signi ficantly improves SIN vector titers, gp91phox expression and reconstitution of superoxide production in X-CGD cells. Gene Ther 16:111-118
135. Naldini L (2006) Inserting optimism into gene therapy. Nat Med 12:386-388
136. Nayak S, Herzog RW (2010) Progress and prospects: immune responses to viral vectors. Gene Ther 17:295-304
137. Niidome T, Huang L (2002) Gene therapy progress and prospects: nonviral vectors. Gene Ther 9:1647-1652
138. Niu Y, Tenney K, Li H, Gimble FS (2008) Engineering variants of the ISceI homing endonuclease with strand-specific and site-specific DNA-nicking activity. J Mol Biol 382:188-202
139. Ogata T, Kozuka T, Kanda T (2003) Identification of an insulator in AAVS1, a preferred region for integration of adeno-associated virus DNA. J Virol 77:9000-9007
140. Ott MG, Schmidt M, Schwarzwaelder K et al (2006) Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat Med 12:401-409
141. Palais G, Nguyen Dinh Cat A, Friedman H et al (2009) Targeted transgenesis at the HPRT locus: an Efficient strategy to achieve tightly controlled in vivo conditional expression with the tet system. Physiol Genomics 37:140-146
142. Palazzoli F, Bire S, Bigot Y, Bonnin-Rouleux F (2011) Landscape of chromatin control element patents: positioning effects in pharmaceutical bioproduction. Nat Biotechnol 29:593-597
143. Papapetrou EP, Sadelain M (2011) Generation of transgene-free human induced pluripotent stem cells with an excisable single polycistronic vector. Nat Protoc 6:1251-1273
144. Papapetrou EP, Lee G, Malani N et al (2011) Genomic safe harbors permit high b-globin transgene expression in thalassemia induced pluripotent stem cells. Nat Biotechnol 29:73-78
145. Park CW, Park J, Kren BT, Steer CJ (2006) Sleeping Beauty transposition in the mouse genome is associated with changes in DNA methylation at the site of insertion. Genomics 88:204-213
146. Paruzynski A, Arens A, Gabriel R et al (2010) Genome-wide high-throughput integrome analyses by nrLAM-PCR and next-generation sequencing. Nat Protoc 5:1379-1395
147. Pavletich NP, Pabo CO (1991) Zinc finger-DNA recognition: crystal structure of a Zif268-DNA complex at 2 1 A. Science 252:809-817
148. Philpott NJ, Gomos J, Falck-Pedersen E (2004) Transgene expression after rep-mediated sitespecific integration into chromosome 19. Hum Gene Ther 15:47-61
149. Pichon C, Billiet L, Midoux P (2010) Chemical vectors for gene delivery: uptake and intracellular traf ficking. Curr Opin Biotechnol 21:640-645
150. Posfai G, Plunkett G III, Feher T et al (2006) Emergent properties of reduced genome Escherichia coli . Science 312:1044-1046
151. Radcliffe PA, Sion CJ, Wilkes FJ et al (2008) Analysis of factor VIII mediated suppression of lentiviral vector titres. Gene Ther 15:289-297
152. Ramachandra CJ, Shahbazi M, Kwang TW et al (2011) Efficient recombinase-mediated cassette exchange at the AAVS1 locus in human embryonic stem cells using baculoviral vectors. Nucleic Acids Res 39:e107
153. Recchia A, Bonini C, Magnani Z et al (2006) Retroviral vector integration deregulates gene expression but has no consequence on the biology and function of transplanted T cells. Proc Natl Acad Sci USA 103:1457-1462
154. Reyes-Sandoval A, Ertl HC (2004) CpG methylation of a plasmid vector results in extended transgene product expression by circumventing induction of immune responses. Mol Ther 9:249-261
155. Rossetti M, Gregori S, Hauben E et al (2011) HIV-1-derived lentiviral vectors directly activate plasmacytoid dendritic cells, which in turn induce the maturation of myeloid dendritic cells. Hum Gene Ther 22:177-188
156. Sakai K, Ohta T, Minoshima S et al (1995) Human ribosomal RNA gene cluster: Identification of the proximal end containing a novel tandem repeat sequence. Genomics 26:521-526
157. Sakurai H, Kawabata K, Sakurai F et al (2008) Innate immune response induced by gene delivery vectors. Int J Pharm 354:9-15
158. Sandmeyer S (2003) Integration by design. Proc Natl Acad Sci USA 100:5586-5588
159. Santoro SW, Schultz PG (2002) Directed evolution of the site specificity of Cre recombinase. Proc Natl Acad Sci USA 99:4185-4190
160. Schambach A, Galla M, Maetzig T et al (2007) Improving transcriptional termination of selfinactivating gamma-retroviral and lentiviral vectors. Mol Ther 15:1167-73
161. Schmidt M, Carbonaro DA, Speckmann C et al (2003) Clonality analysis after retroviral-mediated gene transfer to CD34+ cells from the cord blood of ADA-de ficient SCID neonates. Nat Med 9:463-468
162. Schmidt M, Schwarzwaelder K, Bartholomae C et al (2007) High-resolution insertion-site analysis by linear ampli fication-mediated PCR (LAM-PCR). Nat Methods 4:1051-1057
163. Schroder AR, Shinn P, Chen H et al (2002) HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110:521-529
164. Shi X, Harrison RL, Hollister JR et al (2007) Construction and characterization of new piggyBac vectors for constitutive or inducible expression of heterologous gene pairs and the Identification of a previously unrecognized activator sequence in piggyBac . BMC Biotechnol 7:5
165. Sioud M (2006) Innate sensing of self and non-self RNAs by Toll-like receptors. Trends Mol Med 12:167-176
166. Sjeklocha L, Chen Y, Daly MC et al (2011) b-globin matrix attachment region improves stable genomic expression of the Sleeping Beauty transposon. J Cell Biochem 112:2361-2375
167. Smith J, Grizot S, Arnould S et al (2006) A combinatorial approach to create artificial homing endonucleases cleaving chosen sequences. Nucleic Acids Res 34:e149
168. Sorrell DA, Kolb AF (2005) Targeted modification of mammalian genomes. Biotechnol Adv 23:431-469
169. Strathdee D, Ibbotson H, Grant SG (2006) Expression of transgenes targeted to the Gt(ROSA)26Sor locus is orientation dependent. PLoS One 1:e4
170. Su K, Wang D, Ye J et al (2009) Site-specific integration of retroviral DNA in human cells using fusion proteins consisting of human immunode ficiency virus type 1 integrase and the designed polydactyl zinc-finger protein E2C. Methods 47:269-276
171. Sumiyoshi T, Holt NG, Hollis RP et al (2009) DB Stable transgene expression in primitive human CD34+ hematopoietic stem/progenitor cells using the Sleeping Beauty transposon system. Hum Gene Ther 20:1607-1626
172. Suzuki R, Oda Y, Utoguchi N, Maruyama K (2011) Progress in the development of ultrasoundmediated gene delivery systems utilizing nanoand microbubbles. J Control Release 149: 36-41
173. Szczepek M, Brondani V, Büchel J et al (2007) Structure-based redesign of the dimerization interface reduces the toxicity of zinc-finger nucleases. Nature Biotech 25:786-793
174. Takahashi H, Fujiwara H (1999) Transcription analysis of the telomeric repeat-specific retrotransposons TRAS1 and SART1 of the silkworm Bombyx mori. Nucleic Acids Res 27:2015-2021
175. Takahashi H, Fujiwara H (2002) Transplantation of target site specificity by swapping the endonuclease domains of two LINEs. EMBO J 21:408-417
176. Takiguchi N, Takahashi Y, Nishikawa M et al (2011) Positive correlation between the generation of reactive oxygen species and activation/reactivation of transgene expression after hydrodynamic injections into mice. Pharm Res 28:702-711
177. Tham WH, Zakian VA (2002) Transcriptional silencing at Saccharomyces telomeres: implications for other organisms. Oncogene 21:512-521
178. Thierry A, Dujon B (1992) Nested chromosomal fragmentation in yeast using the meganuclease I-Sce I: a new method for physical mapping of eukaryotic genomes. Nucleic Acids Res 20: 5625-5631
179. Thyagarajan B, Olivares EC, Hollis RP et al (2001) Site-specific genomic integration in mammalian cells mediated by phage phiC31 integrase. Mol Cell Biol 21:3926-3934
180. Trinh AT, Ball BG, Weber E et al (2009) Retroviral vectors encoding ADA regulatory locus control region provide enhanced T-cell-specific transgene expression. Genet Vaccines Ther 30:7-13
181. Turan S, Galla M, Ernst E et al (2011) Recombinase-mediated cassette exchange (RMCE): traditional concepts and current challenges. J Mol Biol 407:193-221
182. Turlure F, Devroe E, Silver PA et al (2004) Human cell proteins and human immunode ficiency virus DNA integration. Front Biosci 9:3187-3208
183. Un K, Kawakami S, Suzuki R et al (2011) Suppression of melanoma growth and metastasis by DNA vaccination using an ultrasound-responsive and mannose-modified gene carrier. Mol Pharm 8:543-554
184. Urnov FD, Rebar EJ, Holmes MC, Zhang HS, Gregory PD (2010) Genome editing with engineered zinc finger nucleases. Nat Rev Genet 11:636-646
185. Valenzuela L, Kamakaka RT (2006) Chromatin insulators. Annu Rev Genet 40:107-138
186. Vigdal TJ, Kaufman CD, Izsvak Z et al (2002) Common physical properties of DNA affecting target site selection of sleeping beauty and other Tc1/mariner transposable elements. J Mol Biol 323:441-452
187. Violot S, Hong SS, Rakotobe D et al (2003) The human polycomb group EED protein interacts with the integrase of human immunode ficiency virus type 1. J Virol 77:12507-12522
188. Voigt K, Izsvák Z, Ivics Z (2008) Targeted gene insertion for molecular medicine. J Mol Med 86:1205-1219
189. Voziyanov Y, Konieczka JH, Stewart AF, Jayaram M (2003) Stepwise manipulation of DNA specificity in Flp recombinase: progressively adapting Flp to individual and combinatorial mutations in its target site. J Mol Biol 326:65-76
190. Wade-Martins R (2011) Developing extrachromosomal gene expression vector technologies: an overview. Methods Mol Biol 738:1-17
191. Wahlers A, Schwieger M, Li Z et al (2001) In fluence of multiplicity of infection and protein stability on retroviral vector mediated gene expression in hematopoietic cells. Gene Ther 8:477-486
192. Walisko O, Izsvák Z, Szabó K et al (2006) Sleeping Beauty transposase modulates cell-cycle progression through interaction with Miz-1. Proc Natl Acad Sci USA 103:4062-4067
193. Ward NJ, Buckley SM, Waddington SN (2011) Codon optimization of human factor VIII cDNAs leads to high-level expression. Blood 117:798-807
194. Wegel E, Shaw P (2005) Gene activation and deactivation related changes in the three-dimensional structure of chromatin. Chromosoma 114:331-337
195. Wei G, Wei L, Zhu J (2009) Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity 30:155-167
196. Wheelan S, Scheifele LZ, Martínez-Murillo F et al (2006) Transposon insertion site pro filing chip (TIP-chip). Proc Natl Acad Sci USA 103:17632-17637
197. Wilber A, Frandsen JL, Geurts JL et al (2006) RNA as a source of transposase for Sleeping Beautymediated gene insertion and expression in somatic cells and tissues. Mol Ther 13:625-630
198. Wilson MH, George AL Jr (2010) Designing and testing chimeric zinc finger transposases. Methods Mol Biol 649:353-363
199. Wirth D, Gama-Norton L, Riemer P et al (2007) Road to precision: recombinase-based targeting technologies for genome engineering. Curr Opin Biotechnol 18:411-419
200. Woltjen K, Mickael IP, Mohseni P et al (2009) piggyBac transposition reprograms fIbroblasts to induced pluripotent stem cells. Nature 458:766-770
201. Wu X, Li Y, Crise B, Burgess SM (2003) Transcription start regions in the human genome are favored targets for MLV integration. Science 300:1749-1751
202. Wu SC, Meir YJ, Coates CJ et al (2006) PiggyBac is a flexible and highly active transposon as compared to sleeping beauty, Tol2, and Mos1 in mammalian cells. Proc Natl Acad Sci USA 103:15008-15013
203. Wu Z, Sun J, Zhang T et al (2008) Optimization of self-complementary AAV vectors for liverdirected expression results in sustained correction of hemophilia B at low vector dose. Mol Ther 16:280-289
204. Xie W, Gai X, Zhu Y (2001) Targeting of the yeast Ty5 retrotransposon to silent chromatin is mediated by interactions between integrase and Sir4p. Mol Cell Biol 21:6606-6614
205. Xue X, Huang X, Nodland SE et al (2009) Stable gene transfer and expression in cord blood-derived CD34+ hematopoietic stem and progenitor cells by a hyperactive Sleeping Beauty transposon system. Blood 114:1319-1330
206. Yamamoto A, Kormann M, Rosenecker J et al (2009) Current prospects for mRNA gene delivery. Eur J Pharm Biopharm 71:484-489
207. Yant SR, Kay MA (2003) Nonhomologous-end-joining factors regulate DNA repair fidelity during Sleeping Beauty element transposition in mammalian cells. Mol Cell Biol 23:8505-8518
208. Yant SR, Wu X, Huang Y et al (2005) High-resolution genome-wide mapping of transposon integration in mammals. Mol Cell Biol 25:2085-2094
209. Yant SR, Huang Y, Akache B, Kay MA (2007) Site-directed transposon integration in human cells. Nucleic Acids Res 35:e50
210. Yao S, Sukonnik T, Kean T, Bharadwaj RR, Pasceri P, Ellis J (2004) Retrovirus silencing, variegation, extinction, and memory are controlled by a dynamic interplay of multiple epigenetic modifications. Mol Ther 10:27-36
211. Yew NS (2005) Controlling the kinetics of transgene expression by plasmid design. Adv Drug Deliv Rev 57:769-780
212. Yew NS, Zhao H, Przybylska M et al (2002) CpG-depleted plasmid DNA vectors with enhanced safety and long-term gene expression in vivo . Mol Ther 5:731-738
213. Yoder JA, Walsh CP, Bestor TH (1997) Cytosine methylation and the ecology of intragenomic parasites. Trends Genet 13:335-340
214. Yoder KE, Espeseth A, Wang XH et al (2011) The base excision repair pathway is required for Efficient lentivirus integration. PLoS One 6:e17862
215. Yusa K, Takeda J, Horie K (2004) Enhancement of Sleeping Beauty transposition by CpG methylation: possible role of heterochromatin formation. Mol Cell Biol 24:4004-4018
216. Yusa K, Rad R, Takeda J, Bradley A (2009) Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon. Nat Methods 6:363-369
217. Zaldumbide A, Hoeben RC (2008) How not to be seen: immune-evasion strategies in gene therapy. Gene Ther 15:239-246
218. Zambrowicz BP, Imamoto A, Fiering S et al (1997) Disruption of overlapping transcripts in the ROSA b geo 26 gene trap strain leads to widespread expression of b-galactosidase in mouse embryos and hematopoietic cells. Proc Natl Acad Sci USA 94:3789-3794
219. Zayed H, Izsvaak S, Khare D et al (2003) The DNA-bending protein HMGB1 is a cellular cofactor of Sleeping Beauty transposition. Nucleic Acids Res 31:2313-2322
220. Zeh DW, Zeh JA, Ishida Y (2009) Transposable elements and an epigenetic basis for punctuated equilibria. Bioessays 31:715-726
221. Zhang C (2009) Novel functions for small RNA molecules 1. Curr Opin Mol Ther 11:641-651
222. Zhou R, Norton JE, Zhang N, Dean DA (2007) Electroporation-mediated transfer of plasmids to the lung results in reduced TLR9 signaling and in flammation. Gene Ther 14:775-780
223. Zhou H, Liu ZG, Sun ZW et al (2010) Generation of stable cell lines by site-specific integration of transgenes into engineered Chinese hamster ovary strains using an FLP-FRT system. J Biotechnol 147:122-129
224. Zhu J, Park CW, Sjeklocha L et al (2010) High-level genomic integration, epigenetic changes, and expression of sleeping beauty transgene. Biochemistry 49:1507-1521
225. Zychlinski D, Schambach A, Modlich U et al (2008) Physiological promoters reduce the genotoxic risk of integrating gene vectors. Mol Ther 16:718-725